Apex Healthcare Berhad

    Apex Healthcare Berhad

    MMYX:7090
    2.61
    MYR
    0.00
    (0.00%)
    23.95P/E
    Apex Healthcare Berhad
    MYX:7090
    (Bursa Malaysia)

    Recent

    price

    2.61

    P/E

    ratio

    23.95

    div

    yld

    - -

    ROIC.AI

    2009
    2010
    2011
    2012
    2013
    2014
    2015
    2016
    2017
    2018
    2019
    2020
    2021
    2022
    2023
    2024
    TTM
    MYR
    0.5
    0.45
    0.52
    0.57
    0.6
    0.71
    0.75
    0.83
    0.88
    0.93
    0.97
    0.98
    1.08
    1.23
    1.31
    1.34
    1.33
    Revenue per Share
    0.04
    0.05
    0.04
    0.04
    0.04
    0.05
    0.05
    0.05
    0.06
    0.08
    0.07
    0.08
    0.08
    0.14
    0.56
    0.11
    0.1
    Basic EPS, GAAP
    0.05
    0.03
    0.03
    0.03
    -0.01
    0.04
    0.02
    0.03
    0.02
    -0.03
    0.08
    0.1
    0.07
    0.06
    0.05
    0.05
    0.11
    Free Cash Flow per Basic Share
    0.01
    0.02
    0.02
    0.02
    0.02
    0.01
    0.02
    0.02
    0.02
    0.02
    0.02
    0.02
    0.04
    0.08
    0.06
    0.29
    0.06
    Dividend per Share
    0.27
    0.26
    0.28
    0.31
    0.33
    0.36
    0.39
    0.42
    0.47
    0.53
    0.58
    0.64
    0.69
    0.76
    1.25
    1.08
    1.1
    Book Value per Share
    0.3
    0.28
    0.3
    0.31
    0.33
    0.37
    0.41
    0.44
    0.49
    0.55
    0.6
    0.66
    0.71
    0.78
    1.28
    1.09
    1.11
    Tangible Book Value per Share
    562
    703
    703
    703
    703
    703
    703
    703
    703
    704
    707
    710
    710
    711
    714
    715
    715
    Basic Weighted Avg Shares
    283
    314
    366
    399
    418
    499
    527
    581
    620
    653
    689
    699
    771
    878
    936
    962
    954
    Sales/Revenue/Turnover
    8.38
    9.4
    9.17
    9.84
    9.3
    8.1
    7.57
    6.93
    7.03
    8.54
    7.82
    7.65
    7.98
    9.59
    7.79
    10.05
    10.38
    Operating Margin (%)
    6
    6
    7
    7
    8
    9
    9
    9
    10
    9
    16
    16
    16
    16
    18
    22
    23
    Depreciation Expense
    22
    33
    28
    29
    30
    34
    34
    35
    44
    59
    53
    56
    59
    101
    398
    77
    68
    Net Income, GAAP
    18.42
    14.98
    20.63
    31.36
    25.83
    25.53
    25.26
    24.42
    20.62
    15.31
    20.45
    20.18
    21.18
    16.11
    5.98
    24.36
    26.87
    Effective Tax Rate (%)
    7.83
    10.5
    7.65
    7.28
    7.17
    6.78
    6.5
    6.01
    7.17
    8.98
    7.66
    8.02
    7.71
    11.5
    42.51
    7.96
    7.13
    Profit Margin (%)
    78
    83
    85
    136
    114
    136
    164
    186
    189
    204
    241
    256
    300
    294
    515
    377
    416
    Working Capital
    9
    7
    1
    - -
    - -
    - -
    - -
    - -
    - -
    24
    23
    6
    15
    9
    6
    48
    43
    LT Debt
    172
    198
    212
    216
    235
    260
    289
    312
    344
    386
    426
    468
    507
    558
    918
    790
    805
    Total Equity
    10.76
    12.71
    12.58
    12.49
    12.8
    12.17
    10.86
    10.13
    10.53
    12.41
    9.87
    9
    9.49
    12.83
    9.11
    8.22
    8.57
    Return on Invested Capital (%)
    12.06
    14.68
    13.16
    13.49
    13.4
    13.83
    12.83
    12.12
    14.13
    15.94
    12.72
    12.28
    12.04
    19.02
    54.56
    8.95
    8.54
    Return on Capital (%)
    15.63
    19.78
    14.68
    14.04
    13.45
    13.9
    12.85
    12.14
    14.16
    16.64
    13.39
    12.89
    12.53
    19.59
    55.49
    9.18
    8.69
    Return on Common Equity (%)

    Capital Structure

    MYR

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    ST Debt
    9
    9
    9
    LT Borrowings
    40
    38
    36
    LT Finance Leases
    8
    7
    7
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    720
    720
    720
    Market Capitalization
    1,766
    1,516
    1,631

    Working Capital

    MYR

    •

    in mil. unless spec.
    Dec'24
    Mar'25
    Jun'25
    Total Current Assets
    540
    559
    575
    Cash, Cash Equivalents & STI
    214
    227
    228
    Accounts Receivable, Net
    181
    190
    203
    Inventories
    132
    139
    141
    Total Current Liabilities
    163
    163
    160
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    9
    9
    9
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    MYR

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    13.06%
    15.78%
    -14.01%
    Free Cash Flow
    -69.92%
    -4.59%
    2.26%
    Net Income, GAAP
    34.78%
    59.12%
    -80.77%
    Sales/Revenue/Turnover
    6.84%
    7.01%
    2.74%
    Total Cash Common Dividend
    - -
    103.85%
    363.25%

    Quarterly Revenue

    MYR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    246
    215
    235
    240
    936
    2024
    248
    239
    237
    238
    962
    2025
    239
    241
    - -
    - -
    - -

    Quarterly Earnings Per Share

    MYR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    0.03
    0.46
    0.03
    0.03
    0.56
    2024
    0.03
    0.03
    0.03
    0.02
    0.11
    2025
    0.02
    0.03
    - -
    - -
    - -

    Quarterly Dividends Per Share

    MYR

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    0.03
    - -
    0.06
    2024
    - -
    - -
    0.03
    0.03
    0.29
    2025
    - -
    - -
    - -
    - -
    - -
    Similar Companies
    Business